Substance Abuse Disorders Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

BioCorRx Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, Oct. 13, 2022. BioCorRx Inc. (the“Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that the last subject has been enrolled in the Phase I... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 13, 2022 Category: Pharmaceuticals Source Type: clinical trials

The Social Competence Promotion Program among Young Adolescents (SCPP-YA) in Chile ( “Mi Mejor Plan”) for substance use prevention among early adolescents: study protocol for a randomized controlled trial
DiscussionThe proposed study will be the first to test the effectiveness of the Social Competence Promotion Program among Young Adolescents (SCPP-YA) in Chile in a cluster randomized control trial and also the first study evaluating this program in Spanish-speaking Latin America. SCPP-YA has been implemented successfully in the USA. Thus, if the effects of the program are positive, wide implementation in Chile and Latin American countries is possible soon.Trial registrationClinical TrialsNCT04236947. Registered on January 22, 2020. (Source: Trials)
Source: Trials - June 30, 2022 Category: Research Source Type: clinical trials

Effectiveness and cost-effectiveness of sector-independent treatment coordination for people with substance-related disorders following an online assessment (ASSIST): study protocol for a randomized controlled trial
DiscussionThe results of this study are expected to provide information on whether sector-independent treatment coordination following an online assessment contributes to improved health care service provision for people with substance-related problems. This randomized controlled trial will help identify facilitators and barriers to the sustainable implementation of a cross-sectoral care concept in substance abuse services.Trial registrationGerman Clinical Trial RegisterDRKS00026996. Registered on 29 October 2021 (Source: Trials)
Source: Trials - June 1, 2022 Category: Research Source Type: clinical trials

Skills Group for Those at Clinical High-Risk for Psychosis
Conditions: Clinical High-Risk; Psychological Intervention: Behavioral: Skills Group Sponsors: University of Pittsburgh; Substance Abuse and Mental Health Services Administration (SAMHSA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2022 Category: Research Source Type: clinical trials